ChemLifeIntel
Access

Prussian Blue Insoluble Capsules

TRACKED

Decorporation Agent

CASHSN
THERAPEUTIC AREAS
MOLECULE INTELLIGENCE SNAPSHOTlive
14
Manufacturers monitored
38
Intelligence briefs
3
Active regulatory actions
₹2,800 Cr
Est. India export value

INTELLIGENCE

Showing 1 of 1 briefs for Prussian Blue Insoluble Capsules
REGULATORY INTELLIGENCE·Recall

FDA Class II Recall: Herbal Doctor Remedies' Detoxin-S Deemed Unapproved and Misbranded

Herbal Doctor Remedies faced an FDA Class II recall for Detoxin-S 500mg Capsules due to CGMP deviations, rendering them unapproved new drugs and misbranded. This voluntary, firm-initiated recall, active from March 2020 to January 2024, impacted online and international markets, highlighting critical compliance risks for procurement and regulatory teams globally.

90-Day Activity
PSPriya Subramaniam· Intelligence Analyst
2020-04-15